Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update

Key Points

• Short interest surged 82.5% in April to 2,294,430 shares (about 6.2% of the stock), yielding a short-interest ratio of 3.1 days based on average daily volume.
• Analyst coverage is mixed: two Buys and one Sell result in a consensus "Hold" with an average price target of $21.50, while recent notes include Leerink's "Outperform" ($23) and HC Wainwright's $20 target.
• Institutional ownership stands at 35.21%, and hedge fund SmartHarvest increased its stake to 16,367 shares (approximately $113,000) in Q1.

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,294,430 shares, an increase of 82.5% from the March 31st total of 1,257,504 shares. Approximately 6.2% of the shares of the stock are short sold. Based on an average trading volume of 731,079 shares, the short-interest ratio is presently 3.1 days.

Institutional Investors Weigh In On Adlai Nortye

A hedge fund recently raised its stake in Adlai Nortye stock. SmartHarvest Portfolios LLC raised its stake in shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Free Report) by 8.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 16,367 shares of the company's stock after buying an additional 1,279 shares during the quarter. SmartHarvest Portfolios LLC's holdings in Adlai Nortye were worth $113,000 at the end of the most recent reporting period. 35.21% of the stock is owned by institutional investors and hedge funds.

Adlai Nortye Stock Performance

Shares of NASDAQ:ANL opened at $14.80 on Monday. The business's fifty day moving average price is $9.89 and its two-hundred day moving average price is $5.19. Adlai Nortye has a one year low of $0.88 and a one year high of $17.25.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ANL. Wall Street Zen upgraded Adlai Nortye to a "hold" rating in a report on Saturday, March 7th. Leerink Partners started coverage on Adlai Nortye in a report on Friday, March 20th. They issued an "outperform" rating and a $23.00 price target on the stock. Weiss Ratings reiterated a "sell (e+)" rating on shares of Adlai Nortye in a report on Wednesday, January 21st. Finally, HC Wainwright increased their target price on Adlai Nortye from $16.00 to $20.00 and gave the company a "buy" rating in a report on Monday, April 20th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Adlai Nortye currently has a consensus rating of "Hold" and an average price target of $21.50.

About Adlai Nortye

Adlai Nortye Inc NASDAQ: ANL is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.